Sandra D'Ascenzo
Biography
Overview
Sandra D'Ascenzo has been a member of the real estate practice group in the Frankfurt office since 2017.
She provides legal advice to national and international clients on all real estate-related matters, including real estate transactions, real estate-related M&A transactions, real estate financing and the restructuring of real estate companies, project developments and asset management in all asset classes, with a particular focus on data centers.
Experience
Advised x+bricks Group on the sale of its grocery-anchored retail property portfolio valued at over €1 billion to Slate Asset Management, a global alternative investment platform targeting real assets.
Advised Mercedes-Benz on the cooperation agreement for its strategic partnership with energy company E.ON for the establishment and operation of the new Europe-wide Mercedes-Benz charging network, which enables fast, safe and environmentally friendly charging of electric vehicles.
Advised Adler Group S.A. on the sale of 14,400 residential and commercial units, predominantly located in medium-sized cities in eastern Germany, to international investment company KKR and German real estate specialist Velero.
Advised x+bricks group on approx. €500 Million acquisition of 120 grocery-anchored properties from TLG Immobilien AG and its subsidiaries.
Advised Interxion, a Digital Realty Company, a leading global provider of data center services, on the acquisition of data center campus Hanauer Landstrasse in Frankfurt, Germany from IntReal International Real Estate Kapitalverwaltungsgesellschaft mbH.
Advised Colt Technology Services, a multinational telecommunications company, on the carve-out and subsequent sale of twelve data centers across its Europe portfolio to AtlasEdge.
Advised LANXESS on the sale of its stake in chemical park operator Currenta to funds managed by Macquarie Infrastructure and Real Assets (MIRA), one of the world's largest infrastructure investors and sale of the real estate and infrastructure facilities located in the CHEMPARK from subsidiaries of Bayer AG to Currenta.
